Edap Tms S.a. (ADR)
General ticker "EDAP" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $105.8M (TTM average)
Edap Tms S.a. (ADR) follows the US Stock Market performance with the rate: 46.3%.
Estimated limits based on current volatility of 2.5%: low 4.96$, high 5.21$
Factors to consider:
- Total employees count: 289 as of 2025
- Top business risk factors: Inability to raise capital, HIFU technology success, Trade tariffs, Industry cyclicity, Liquidity and credit risks
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.90$, 4.81$]
- 2026-12-31 to 2027-12-31 estimated range: [1.70$, 4.35$]
Financial Metrics affecting the EDAP estimates:
- Positive: with PPE of -3.9 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0.25 <= 0.28
- Positive: Inventory ratio change, % of -9.13 <= -0.75
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term EDAP quotes
Long-term EDAP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €60.42MM | €64.11MM | €70.53MM |
| Operating Expenses | €80.24MM | €84.65MM | €95.22MM |
| Operating Income | €-19.81MM | €-20.53MM | €-24.69MM |
| Non-Operating Income | €-0.72MM | €1.80MM | €-4.11MM |
| Interest Expense | €0.23MM | €0.24MM | €0.00MM |
| R&D Expense | €6.96MM | €7.73MM | €9.66MM |
| Income(Loss) | €-20.53MM | €-18.73MM | €-28.81MM |
| Taxes | €0.64MM | €0.29MM | €0.44MM |
| Net Income(Loss)* | €-21.18MM | €-19.02MM | €-29.34MM |
| Stockholders Equity | €56.92MM | €42.48MM | €19.41MM |
| Inventory | €15.11MM | €18.50MM | €10.92MM |
| Assets | €91.55MM | €89.41MM | €79.00MM |
| Operating Cash Flow | €-14.68MM | €-13.58MM | €-16.41MM |
| Capital expenditure | €4.30MM | €4.10MM | €5.76MM |
| Investing Cash Flow | €-4.34MM | €-4.12MM | €-5.71MM |
| Financing Cash Flow | €-0.91MM | €4.63MM | €8.61MM |
| Earnings Per Share** | €-0.57 | €-0.51 | €-0.78 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.